Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fu

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Journal of Sport Rehabilitation|February 22, 2023
A Systematic Review of Lower-Body Kinematic and Strength Factors Associated With Pitch Velocity in Adult Baseball PitchersJoseph E Manzi, Jonathan S Yu, Suleiman Y Sudah, et al.
Journal of the American Heart Association|April 21, 2018
Although Coronary Mortality Has Decreased, Rates of Cardiovascular Disease Remain High: 21 Years of Follow-Up Comparing Cohorts of Men Born in 1913 With Men Born in 1943Michael Fu, Annika Rosengren, Erik Thunström, et al.
European Journal of Heart Failure|May 25, 2010
Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) StudyNikolas Deubner, Dominik Berliner, Angela Schlipp, et al.
Cardiac Failure Review|August 9, 2017
Sleep-disordered Breathing in Heart Failure - Current State of the ArtMartin R Cowie, Holger Woehrle, Olaf Oldenburg, et al.
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
JACC. Heart Failure|September 16, 2025
Frailty and Effects of Semaglutide in Obesity-Related HFpEF: Findings From the STEP-HFpEF ProgramAmbarish Pandey, Dalane W Kitzman, Khaja M Chinnakondepalli, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
European Journal of Heart Failure|September 16, 2024
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and designLars H Lund, Stefan James, Adam D DeVore, et al.
European Heart Journal|December 22, 2020
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetesWilliam T Abraham, JoAnn Lindenfeld, Piotr Ponikowski, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Journal of Sport Rehabilitation|February 22, 2023
A Systematic Review of Lower-Body Kinematic and Strength Factors Associated With Pitch Velocity in Adult Baseball PitchersJoseph E Manzi, Jonathan S Yu, Suleiman Y Sudah, et al.
Journal of the American Heart Association|April 21, 2018
Although Coronary Mortality Has Decreased, Rates of Cardiovascular Disease Remain High: 21 Years of Follow-Up Comparing Cohorts of Men Born in 1913 With Men Born in 1943Michael Fu, Annika Rosengren, Erik Thunström, et al.
European Journal of Heart Failure|May 25, 2010
Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) StudyNikolas Deubner, Dominik Berliner, Angela Schlipp, et al.
Cardiac Failure Review|August 9, 2017
Sleep-disordered Breathing in Heart Failure - Current State of the ArtMartin R Cowie, Holger Woehrle, Olaf Oldenburg, et al.
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
JACC. Heart Failure|September 16, 2025
Frailty and Effects of Semaglutide in Obesity-Related HFpEF: Findings From the STEP-HFpEF ProgramAmbarish Pandey, Dalane W Kitzman, Khaja M Chinnakondepalli, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
European Journal of Heart Failure|September 16, 2024
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and designLars H Lund, Stefan James, Adam D DeVore, et al.
European Heart Journal|December 22, 2020
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetesWilliam T Abraham, JoAnn Lindenfeld, Piotr Ponikowski, et al.
Pageof 21